Step 2: Customized Protocol If appropriate, we design a treatment plan that may include BPC-157, TB-500, or bothalongside physical therapy, rehabilitation, or other modalities
The referral destination depends on the accompanying findings: liver findings may point to hepatology or gastroenterology, significant kidney disease to nephrology, abnormal counts or smear findings to hematology, and cancer concern to oncology
not for human or veterinary applications
A fresh NAD+ solution should be clear and colorless
If you experience a suspected adverse reaction to any medicine or substance including unlicensed compounds you can report this to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk
Easy to use guide for a newbie such as myself